biote Stock (NASDAQ:BTMD)
Previous Close
$1.54
52W Range
$1.39 - $4.75
50D Avg
$2.17
200D Avg
$2.99
Market Cap
$66.99M
Avg Vol (3M)
$176.21K
Beta
1.14
Div Yield
-
BTMD Company Profile
biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile pellet insertion kits for men and women. The company was founded in 2011 and is headquartered in Irvine, Texas.
BTMD Performance
Revenue Breakdown
Revenue Breakdown by Product/Service
Annual
| Product/Service | Dec 25 | Dec 24 | Dec 23 |
|---|---|---|---|
| Dietary Supplements | $42.88M | $36.02M | $38.09M |
| Other Service Revenue | $2.86M | $2.27M | $697.00K |
| Product Revenue | $186.92M | $192.24M | $182.57M |
| Service Revenue | $5.29M | $4.95M | $2.79M |
| Training Service Revenue | $1.08M | $1.46M | $1.17M |
Latest
Fiscal year ends in Dec 25 | Currency in USD